DIN 02512963 — BRUKINSA 80 MG
BRUKINSA is a capsule of Zanubrutinib marketed by BEONE MEDICINES I GMBH. The full Zanubrutinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02512963
- Brand name
- BRUKINSA
- Active ingredient
- Zanubrutinib
- Strength
- 80 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BEONE MEDICINES I GMBH
- Health Canada status
- MARKETED
- Drug class
- Bruton's tyrosine kinase (BTK) inhibitor (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Zanubrutinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02554267 | BRUKINSA | 160 MG | TABLET | BEONE MEDICINES I GMBH | MARKETED |